Announce Date | 05/08/2025 |
EPS Normalized Actual | $0.81 (Beat by $0.08) |
EPS GAAP Actual | $0.81 (Beat by $0.08) |
Revenue Actual | $12.712B |
Revenue Surprise | Beat by $12712M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $2.68751 |
EPS GAAP Estimate | $2.68751 |
Revenue Estimate | $8.037742663B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 4.29307 | 7.51 | 3.90831 | 4.84237 | 1 |
Dec 2028 | 0 | INF | 0 | 0 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.17 | -1.11343 | 12.712B | 35.15% | 5155.77M |
FQ4 2024 (Dec 2024) | 0.54 | -0.54486 | 9.468B | -0.9% | 162.28M |
FQ3 2024 (Sep 2024) | 1.07 | -0.47141 | 10.401B | -13.09% | -9502.5M |
FQ2 2024 (Jun 2024) | 0.8 | 0.8 | 9.051B | 2.26% | 9051M |
FQ1 2024 (Mar 2024) | 0.92 | 0.92 | 8.244B | -15.82% | 8244M |
FQ4 2023 (Dec 2023) | 2.41 | 2.41 | 9.553B | -15.27% | 9553M |
FQ3 2023 (Sep 2023) | 2.15 | 2.15 | 11.762B | -6.9% | 11762M |
FQ2 2023 (Jun 2023) | 1.34 | 1.34 | 8.846B | 100% | 8846M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
2.68751
Consensus Revenue Estimates
8.037742663B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.82492 | -- | 0.81109 | 0.83875 | 3 |
FQ3 2027 (Sep 2027) | 0.82492 | -- | 0.81109 | 0.83875 | 3 |
FQ2 2027 (Jun 2027) | 0.81509 | -- | 0.80143 | 0.82875 | 3 |
FQ1 2027 (Mar 2027) | 0.80527 | -- | 0.79177 | 0.81877 | 3 |
FQ4 2026 (Dec 2026) | 1.1122 | -- | 1.05551 | 1.15588 | 2 |
FQ3 2026 (Sep 2026) | 1.99859 | -- | 1.69151 | 2.21426 | 1 |
FQ2 2026 (Jun 2026) | 1.95728 | -- | 1.65654 | 2.16849 | 1 |
FQ1 2026 (Mar 2026) | 1.91683 | 38.96 | 1.62231 | 2.12368 | 1 |
FQ4 2025 (Dec 2025) | 1.10466 | 51.12 | 1.04836 | 1.14805 | 5 |
FQ3 2025 (Sep 2025) | 2.68751 | 60.19 | 2.27457 | 2.97753 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 9.19B | -- | 9.07B | 9.31B | 1 |
FQ3 2027 (Sep 2027) | 9.13B | -- | 9.01B | 9.25B | 1 |
FQ2 2027 (Jun 2027) | 9.07B | -- | 8.95B | 9.19B | 1 |
FQ1 2027 (Mar 2027) | 9.01B | -- | 8.89B | 9.12B | 1 |
FQ4 2026 (Dec 2026) | 9.87B | -- | 9.49B | 10.17B | 2 |
FQ3 2026 (Sep 2026) | 7.6B | -- | 6.7B | 8.23B | 1 |
FQ2 2026 (Jun 2026) | 7.52B | -- | 6.63B | 8.15B | 1 |
FQ1 2026 (Mar 2026) | 7.44B | -70.76 | 6.56B | 8.06B | 1 |
FQ4 2025 (Dec 2025) | 9.73B | 2.65 | 9.34B | 10.02B | 1 |
FQ3 2025 (Sep 2025) | 8.04B | -29.4 | 7.09B | 8.7B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.28343 | 1.17 | -1.11343 | -95.16% |
FQ4 2024 (Dec 2024) | 1.08486 | 0.54 | -0.54486 | -100.9% |
FQ3 2024 (Sep 2024) | 1.54141 | 1.07 | -0.47141 | -44.06% |
FQ2 2024 (Jun 2024) | 0.8 | 0.8 | 100% | |
FQ1 2024 (Mar 2024) | 0.92 | 0.92 | 100% | |
FQ4 2023 (Dec 2023) | 2.41 | 2.41 | 100% | |
FQ3 2023 (Sep 2023) | 2.15 | 2.15 | 100% | |
FQ2 2023 (Jun 2023) | 1.34 | 1.34 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $7.56B | $12.71B | $5155.77M | 40.56% |
FQ4 2024 (Dec 2024) | $9.31B | $9.47B | $162.28M | 1.71% |
FQ3 2024 (Sep 2024) | $19.9B | $10.4B | $-9502.5M | -91.36% |
FQ2 2024 (Jun 2024) | $0B | $9.05B | $9051M | 100% |
FQ1 2024 (Mar 2024) | $0B | $8.24B | $8244M | 100% |
FQ4 2023 (Dec 2023) | $0B | $9.55B | $9553M | 100% |
FQ3 2023 (Sep 2023) | $0B | $11.76B | $11762M | 100% |
FQ2 2023 (Jun 2023) | $0B | $8.85B | $8846M | 100% |